This HTML5 document contains 41 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n11http://linked.opendata.cz/resource/drugbank/drug/DB02826/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n15http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB02826/identifier/chebi/
admshttp://www.w3.org/ns/adms#
n14http://linked.opendata.cz/resource/drugbank/drug/DB02826/identifier/wikipedia/
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n12http://linked.opendata.cz/resource/drugbank/drug/DB02826/identifier/pdb/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02826/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB02826/identifier/pubchem-substance/

Statements

Subject Item
n2:DB02826
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB02826 n15:DB02826
dcterms:title
Decane
adms:identifier
n9:15600 n10:46507334 n11:DB02826 n12:D10 n13:32894 n14:Decane
n3:synthesisReference
Takao Yoshida, "Methyl substituted oxobicyclo-4,4,0-decane derivatives, process for preparing same and organoleptic uses thereof." U.S. Patent US4377714, issued October, 1944.
n3:IUPAC-Name
n4:271B5C27-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5C2D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5C2C-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5C29-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5C2A-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5C2B-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5C25-363D-11E5-9242-09173F13E4C5 n4:271B5C3B-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5C3E-363D-11E5-9242-09173F13E4C5 n4:271B5C26-363D-11E5-9242-09173F13E4C5 n4:271B5C23-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5C24-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5C33-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5C34-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5C2E-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5C2F-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5C31-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5C30-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5C32-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
124-18-5
n3:Bioavailability
n4:271B5C37-363D-11E5-9242-09173F13E4C5
n3:Boiling-Point
n4:271B5C3D-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5C39-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5C3A-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B5C3C-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5C36-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5C35-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5C38-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5C28-363D-11E5-9242-09173F13E4C5